As Senior Solutions Director at Edgescan, Keith plays a key role throughout the entire customer journey—from leading the technical side of business development to ensuring measurable value is delivered long after implementation. With over a decade of experience in technical security roles, including penetration testing, Keith now focuses on helping clients solve complex security challenges and maximizing the impact of the Edgescan platform.
When he’s not identifying and helping to mitigate vulnerabilities in systems, you’ll find him on the mats, trading exploits for takedowns with his sparring partners.
Ahmad holds a PhD in chemistry and microbiology and has been involved with some of the largest FMCG brands’ product pipelines, from ideation through to market access. His primary interests lie in how consumers interact with markets, how markets respond to consumers’ behaviours, and what that interplaymeans for brands. Since joining GlobalData, he has worked extensively with brands looking to better understand consumers purchasing behaviours and sentiments
As a seasoned commercial marketing leader at TraceGains, Bal brings extensive experience blending technology and supply-chain dynamics to drive growth in the food & beverage sector. He works with brands across the industry to showcase digital transformation initiatives and supplier engagement frameworks that connect manufacturers and suppliers through data-driven collaboration, helping global brands embrace digitalisation to accelerate innovation, compliance, and growth.
Cristina Loi is a deeply passionate clinical research professional with more than 5 years of experience in the management of clinical studies involving pharmaceuticals and medical devices across multiple therapeutic areas, including oncology, rare diseases, autoimmune disorders, and orthopaedics. Currently serving as Project Manager at LB Research Srl – Part of 1MED Group, she leads national and international studies across Europe, ensuring compliance, quality, and effective communication among sponsors, regulatory bodies, multiple vendors, and investigational sites.
Amy Hay is an experienced leader in setting strategy, negotiating transactions and implementing global oncology programs. Her expertise lies within identifying synergistic relationships that provide value and her portfolio has ranged from working with health systems, governments, corporations, providers and industry leaders worldwide.
In April 2021, Siemens Healthineers acquired Varian and Amy has been leading integration teams within the oncology workstream to ensure synergies across both organizations are identified and targets are exceeded in commercial acceleration and platform expansion.
Today Amy is responsible for the strategic initiatives and the deployment of “Oncology as a Service” (OaaS), which aggregates medical technology, clinical solutions and technology enabled services globally. Set by her strategy, Varian has built out technology enabled solutions that span virtual tumor boards and molecular analytics. Within her first year, she closed a partnership with Ayala Health in the Philippines and CHRISTUS Health in the US, providing cumulative revenues of more than $75M.
Amy joined Varian through the acquisition of her consulting company, Evolve International, in January of 2020. Evolve provided strategic consulting to healthcare providers, not-for-profit organizations, health related startups and big data technology companies such as the Eliminate Cancer Initiative in Australia, M2GEN at the Moffitt Cancer Center, City of Hope, Nano and the Cancer Commons.
Logan in the Supply Chain and Procurement Lead for the Buchan Offshore Wind Farm. His role is to deliver the Supply Chain Strategy and Procurement roadmap of the project. Logan is a Chartered Civil Engineering surveyor with ten year experience across various sectors including Water, Wastewater, O&M, Electricity transmission and most recently – Offshore Wind – on project such as Dogger Bank, Inch cape and Morecambe Wind Farm.
Ashley McKelvey, Client Director at 4G Clinical, provides strategic leadership and 13 years of experience in enterprise-level RTSM implementation and account management. She has a deep background successfully collaborating with Top 20 Pharma sponsors, leveraging her expertise across various RTSM platforms from both vendor and client perspectives. Ashley is driven by a passion for understanding and simplifying complex clinical trial implementation challenges while ensuring strategic alignment and growth for her enterprise accounts, building meaningful and collaborative partnerships both internally and externally.
Sallie Quinn is a Client Director at 4G Clinical with over a decade of experience in the RTSM industry. She specializes in client governance, strategic account management, and seamless client onboarding. Sallie’s portfolio spans from emerging biotech organizations to Top 10 global pharmaceutical companies. She is passionate about cultivating strong, lasting client relationships and driving operational excellence and alignment across global clinical trial programs.
Remi is a Chartered Engineer with 24 years of experience working across manufacturing industry, academia and industrial facing research organisations. Within NMIS he is the Head of Strategic Planning, where he ensures NMIS is at the cutting-edge of manufacturing and is able to deliver transformational capabilities to Scotland and the wider UK. He is the Senior Responsible Owner for the NMIS Strategic Wind Programme.
Heewon Lee is a Clinical Research Lead at Eli Lilly, responsible for leading the initiation and operation execution of clinical trials for Lilly molecules. Her work focuses on country feasibility, site selection, and investigator engagement. She has over 12 years of experience in the pharmaceutical industry brings deep expertise in clinical operations.
